CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Ames D, Chiu E, Chua P, Yastrubetskaya O, Dingjan P, Draper K, Georgiou-Karistianis N, Goh A, Komiti A, Lemmon C, Paulson H, Bastic K, Conybeare R, Humphreys C, Nopoulos P, Rodnitzky R, Uc E, Beglinger L, Duff K, Magnotta VA, Doucette N, French S, Juhl A, Kuburas H, Mikos A, Reese B, Turner B, Van Der Heiden S, Raymond L, Decolongon J, Rosenblatt A, Ross C, Agarwal A, Gourley L, Shpritz B, Wajda K, Bakker A, Miller R, Mallonee WM, Suter G, Palmer D, Addison J, Jones R, Harrison J, Greenamyre JT, Testa C, McCusker E, Griffith J, Bibb B, Hayes C, Richardson K, Samii A, Lipe H, Bird T, Logsdon R, Weaver K, Field K, Landwehrmeyer BG, Barth K, Niess A, Trautmann S, Ecker D, Held C, Guttman M, Elliott S, Fonariov Z, Giambattista C, Russell S, Sebastian J, Sethna R, Ip R, Shaddick D, Sheinberg A, Stober J, Perlman S, Carroll R, Johnson A, Jackson G, Geschwind MD, Guzijan M, Rose K, Warner T, Kloppel S, Burrows M, Andrews T, Rosser E, Tabrizi S, Golding C, Barker RA, Mason S, Smith E, Rosser A, Naji J, Price K, Handley OJ, Suchowersky O, Furtado S, Klimek ML, Kirstein D, Rosas D, Bennett M, Frishman J, Kaneko Y, Landau T, Lausier M, Muir L, Murphy L, Young A, Skeuse C, Balkema N, Hoogenboom W, Leveroni C, Sherman J, Zaleta A, Panegyres P, Connor C, Woodman M, Zombor R, Perlmutter J, Barton S, Kavanaugh M, Simpson SA, Keenan G, Ure A, Summers F, Craufurd D, Macleod R, Sollom A, Howard E, Quaid K, Wesson M, Wojcieszek J, Beristain X, Mazzoni P, Marder K, Williamson J, Moskowitz C, Wasserman P, Como P, Chesire A, Hickey C, Zimmerman C, Couniham T, Marshall F, Burton C, Wodarski M, Wheelock V, Tempkin T, Baynes K, Jankovic J, Hunter C, Ondo W, Martin C, de Yebenes JG, Garde MB, Fatas M, Schwartz C, Urdanibia JF, Gordaliza CG, Seeberger L, Diamond A, Judd D, Kasunic TL, Mellick L, Montellano S, Kumar R, Schneiders J, Nance M, Radtke D, Norberg D, Tupper D, Martin W, King P, Wieler M, Foster S, Sran S, Dubinsky R, Gray C, Switzer P, Paulsen J, Langbehn D, Johnson H, Aylward E, Biglan K, Kieburtz K, Oakes D, Shoulson I, Guttman M, Hayden M, Landwehrmeyer BG, Nance M, Ross C, Stout J, Blanchard S, Anderson C, Dudler A, Penziner E, Leserman A, Ludwig B, McAreavy B, Murray G, Nehl C, Vik S, Wang C, Werling C, Bourgeois K, Covert C, Daigneault S, Julian-Baros E, Meyers K, Rothenburgh K, Olsen B, Orme C, Ross T, Weber J, Zhao H, Stout JC, Queller S, Johnson SA, Campbell JC, Peters E, Carlozzi NE, Green T, Swain SN, Caughlin D, Ward-Bluhm B, Whitlock K, Paulsen J, Penziner E, Vik S, Agarwal A, Barnes A, Suter G, Jones R, Griffith J, Lipe H, Barth K, Fox M, Guzija M, Zanko A, Naji J, Zombor R, Kavanaugh M, Chesire A, Julian-Baros E, Kayson E, Tempkin T, Nance M, Quaid K, Stout J, Paulsen J, Coryell W, Ross C, Kayson E, Shinaman A, Tempkin T, Nance M, Quaid K, Stout J, Erwin C.
Source
Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242-1000, USA.
Abstract
CAG-repeat length in the gene for HD is inversely correlated with age of onset (AOO). A number of statistical models elucidating the relationship between CAG length and AOO have recently been published. In the present article, we review the published formulae, summarize essential differences in participant sources, statistical methodologies, and predictive results. We argue that unrepresentative sampling and failure to use appropriate survival analysis methodology may have substantially biased much of the literature. We also explain why the survival analysis perspective is necessary if any such model is to undergo prospective validation. We use prospective diagnostic data from the PREDICT-HD longitudinal study of CAG-expanded participants to test conditional predictions derived from two survival models of AOO of HD. A prior model of the relationship of CAG and AOO originally published by Langbehn et al. yields reasonably accurate predictions, while a similar model by Gutierrez and MacDonald substantially overestimates diagnosis risk for all but the highest risk participants in this sample. The Langbehn et al. model appears accurate enough to have substantial utility in various research contexts. We also emphasize remaining caveats, many of which are relevant for any direct application to genetic counseling.
(c) 2009 Wiley-Liss, Inc.
- PMID:
- 19548255
- [PubMed - indexed for MEDLINE]
- PMCID:
- PMC3048807
Free PMC ArticleFigure 1
Mean Onset Age as Estimated by Various Published Formulae
Am J Med Genet B Neuropsychiatr Genet. Am J Med Genet B Neuropsychiatr Genet;153B(2):397-408.
Figure 2
Two-Year Probability of Onset, Predictions from Langbehn et al and Gutierrez and MacDonald versus Prospective Observed Results
Am J Med Genet B Neuropsychiatr Genet. Am J Med Genet B Neuropsychiatr Genet;153B(2):397-408.
Publication Types
MeSH Terms
Substances
Grant Support
Full Text Sources
Other Literature Sources
Medical